|
TDACU Translational Development Acquisition Units 1926599 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$946,982.00 |
| Balance Sheet |
|
Current Assets
|
$104,731.00 |
|
Assets
|
$157,366,598.00 |
|
Current Liabilities
|
$1,751,550.00 |
|
Liabilities
|
$7,789,050.00 |
|
Equity
|
$-7,684,319.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-643,910.00 |
|
Investing Cash Flow
|
$27,617,434.00 |
| Market Analysis |
Market Cap
|
$206,827,500.00 |
|
Price
|
$12.57 |
|
PB
|
2.26 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:19 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:02:08 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TDACU documents filed with the SEC.
TDACU Filings
Clear
